Stock Analysis

An Intrinsic Calculation For Sacyr, S.A. (BME:SCYR) Suggests It's 41% Undervalued

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Sacyr, S.A. (BME:SCYR) as an investment opportunity by taking the forecast future cash flows of the company and discounting them back to today's value. We will use the Discounted Cash Flow (DCF) model on this occasion. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow.

Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you.

View our latest analysis for Sacyr

Advertisement

The model

We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, and so the sum of these future cash flows is then discounted to today's value:

10-year free cash flow (FCF) estimate

2021202220232024202520262027202820292030
Levered FCF (€, Millions) -€271.2m-€212.5m€339.0m€404.0m€450.8m€488.8m€519.2m€543.6m€563.2m€579.3m
Growth Rate Estimate SourceAnalyst x4Analyst x4Analyst x1Analyst x1Est @ 11.57%Est @ 8.43%Est @ 6.23%Est @ 4.69%Est @ 3.61%Est @ 2.86%
Present Value (€, Millions) Discounted @ 16% -€233-€157€216€221€212€198€181€163€145€128

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = €1.1b

After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 1.1%. We discount the terminal cash flows to today's value at a cost of equity of 16%.

Terminal Value (TV)= FCF2030 × (1 + g) ÷ (r – g) = €579m× (1 + 1.1%) ÷ (16%– 1.1%) = €3.9b

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= €3.9b÷ ( 1 + 16%)10= €856m

The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is €1.9b. The last step is to then divide the equity value by the number of shares outstanding. Relative to the current share price of €1.9, the company appears quite good value at a 41% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out.

dcf
BME:SCYR Discounted Cash Flow February 19th 2021

The assumptions

We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Sacyr as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 16%, which is based on a levered beta of 2.000. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Next Steps:

Although the valuation of a company is important, it ideally won't be the sole piece of analysis you scrutinize for a company. It's not possible to obtain a foolproof valuation with a DCF model. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. Why is the intrinsic value higher than the current share price? For Sacyr, we've put together three important elements you should further examine:

  1. Risks: Take risks, for example - Sacyr has 1 warning sign we think you should be aware of.
  2. Future Earnings: How does SCYR's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
  3. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the BME every day. If you want to find the calculation for other stocks just search here.

If you’re looking to trade Sacyr, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted


New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

About BME:SCYR

Sacyr

Engages in the construction and infrastructure concession services businesses worldwide.

Acceptable track record with limited growth.

Advertisement

Weekly Picks

FA
7202 logo
FAI on Arabian Internet and Communication Services ·

Solutions by stc: 34% Upside in Saudi's Digital Transformation Leader

Fair Value:ر.س342.2335.3% undervalued
9 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
RO
RobertoAllende
NVDA logo
RobertoAllende on NVIDIA ·

The AI Infrastructure Giant Grows Into Its Valuation

Fair Value:US$345.0747.9% undervalued
27 users have followed this narrative
28 users have commented on this narrative
21 users have liked this narrative

Updated Narratives

TA
Talos
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$96.3877.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TA
Talos
EVAX logo
Talos on Evaxion ·

The "AI-Immunology" Asymmetric Opportunity – Validated by Merck (MSD)

Fair Value:US$15.8565.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TA
Talos
POET logo
Talos on POET Technologies ·

The Hidden Gem of AI Hardware – Solving the Data Center Bottleneck

Fair Value:US$17.3773.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.6% undervalued
110 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3928.1% undervalued
943 users have followed this narrative
6 users have commented on this narrative
24 users have liked this narrative
OS
oscargarcia
GOOGL logo
oscargarcia on Alphabet ·

The company that turned a verb into a global necessity and basically runs the modern internet, digital ads, smartphones, maps, and AI.

Fair Value:US$3407.4% undervalued
145 users have followed this narrative
6 users have commented on this narrative
18 users have liked this narrative